Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
0.9337
-0.0133 (-1.40%)
At close: Jun 12, 2026, 4:00 PM EDT
0.9005
-0.0332 (-3.56%)
After-hours: Jun 12, 2026, 7:37 PM EDT
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $15.22 million as of June 12, 2026. Its market cap has decreased by -67.81% in one year.
Market Cap
15.22M
Enterprise Value
-2.65M
1-Year Change
-67.81%
Ranking
Category
Stock Price
$0.93
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.58M to $15.22M, a decrease of -98.22%. That is a compound annual growth rate of -43.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 15.22M | -91.84% |
| Dec 31, 2025 | 186.53M | 126.70% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexaria Bioscience | 16.26M |
| Lipocine | 15.89M |
| Sensei Biotherapeutics | 15.31M |
| Vyome Holdings | 15.27M |
| Citius Pharmaceuticals | 15.18M |
| Moolec Science | 15.08M |
| GT Biopharma | 14.97M |
| CalciMedica | 14.67M |